Article Details
Retrieved on: 2021-02-01 06:10:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported ($0.08) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.21) by $0.13. Veracyte ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here